Literature DB >> 2407479

Regulating insulin-receptor-gene expression by differentiation and hormones.

P W Mamula1, A R McDonald, A Brunetti, Y Okabayashi, K Y Wong, B A Maddux, C Logsdon, I D Goldfine.   

Abstract

Insulin regulates cell function by first binding to the insulin receptor (IR) localized on the cell surface. With the cloning of IR cDNA and the IR-gene promoter, the regulation of the IR gene during differentiation and by various hormones can be studied. Muscle is a major target tissue for insulin action. BC3H1 cells, a mouse muscle cell line in culture, are a model cell type for studying insulin action. Differentiation in these cells results in a 5- to 10-fold increase in IR binding and a 5- to 10-fold increase in IR content. Studies of IR mRNA by Northern and slot-blot analyses reveal a 10-fold increase in IR mRNA after differentiation. These studies indicate that there is a selective increase in IR-gene expression during muscle differentiation. A similar increase in IR-gene expression is observed for the IR during pancreatic acinar cell differentiation. Glucocorticoids increase IR content in several target tissues. Studies in cultured IM-9 lymphocytes indicate that glucocorticoids induce a 5-fold increase in IR mRNA levels. Studies of IR mRNA half-life indicate that glucocorticoids do not alter IR mRNA stability. When the transcription of the IR is measured by elongation assays, glucocorticoids directly stimulate IR transcription 5- to 10-fold. The effect is detectable within 30 min of glucocorticoid treatment and is maximal within 2 h. Therefore, these studies demonstrate that the IR gene is under the direct regulation of glucocorticoids. Insulin downregulates the IR in various target tissues. Prior studies indicate that this downregulation was partly because of accelerated IR degradation. Studying AR42J pancreatic acinar cells, we also found that insulin accelerates IR degradation. Moreover, in these cells, insulin decreases IR biosynthesis by approximately 50%. Studies of IR mRNA indicate there is a concomitant decrease in IR mRNA levels after insulin treatment. Thus, insulin decreases IR-gene expression. The genomic structure of the IR promoter has been elucidated. Primer extension and nuclease S1 analysis indicate that IR mRNA has multiple start sites. The promoter fragment was ligated to a promoterless "reporter" plasmid containing the bacterial gene chloramphenicol acetyltransferase (CAT). When this plasmid is transfected into cultured cells, CAT activity is detected, indicating promoter activity. Various portions of a genomic fragment were ligated to a promoter to study glucocorticoid regulation of the IR promoter. These studies indicate that IR-gene expression is regulated by differentiation and hormonal agents.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407479     DOI: 10.2337/diacare.13.3.288

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

Authors:  Pushpendra Singh; Jimi Marin Alex; Felix Bast
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

Review 2.  Regulation of gene expression by insulin.

Authors:  R M O'Brien; D K Granner
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

3.  GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity.

Authors:  Robert Hauffe; Vanessa Stein; Chantal Chudoba; Tanina Flore; Michaela Rath; Katrin Ritter; Mareike Schell; Kristina Wardelmann; Stefanie Deubel; Johannes Florian Kopp; Maria Schwarz; Kai Kappert; Matthias Blüher; Tanja Schwerdtle; Anna P Kipp; André Kleinridders
Journal:  JCI Insight       Date:  2020-06-04

4.  Serum- and growth-factor-free three-dimensional culture system supports cartilage tissue formation by promoting collagen synthesis via Sox9-Col2a1 interaction.

Authors:  Nazish Ahmed; Jonathan Iu; Chelsea E Brown; Drew Wesley Taylor; Rita A Kandel
Journal:  Tissue Eng Part A       Date:  2014-05-29       Impact factor: 3.845

5.  Complex cis-regulatory landscape of the insulin receptor gene underlies the broad expression of a central signaling regulator.

Authors:  Yiliang Wei; Rewatee H Gokhale; Anne Sonnenschein; Kelly Mone't Montgomery; Andrew Ingersoll; David N Arnosti
Journal:  Development       Date:  2016-10-01       Impact factor: 6.868

6.  Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation.

Authors:  A Brunetti; D Foti; I D Goldfine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Transcriptional feedback control of insulin receptor by dFOXO/FOXO1.

Authors:  Oscar Puig; Robert Tjian
Journal:  Genes Dev       Date:  2005-10-15       Impact factor: 11.361

8.  Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects.

Authors:  G Desoye; H H Hofmann; P A Weiss
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

9.  The human insulin receptor mRNA contains a functional internal ribosome entry segment.

Authors:  Keith A Spriggs; Laura C Cobbold; Simon H Ridley; Mark Coldwell; Andrew Bottley; Martin Bushell; Anne E Willis; Kenneth Siddle
Journal:  Nucleic Acids Res       Date:  2009-08-04       Impact factor: 16.971

10.  New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Authors:  Daniela P Foti; Francesco Paonessa; Eusebio Chiefari; Antonio Brunetti
Journal:  PPAR Res       Date:  2009-06-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.